Indaptus Therapeutics, Inc. (INDP) — Stock Price, Chart & Analysis
Indaptus Therapeutics, Inc. (INDP) is a Healthcare stock currently trading at $3.99, up 29.13% on the day. It carries a market capitalization of $531.64M. Over the past 52 weeks, INDP has traded between $0.92 and $8.57. Indaptus Therapeutics, Inc. does not currently pay a regular dividend. View the live INDP chart, technical opinion, analyst ratings, fundamentals and latest news below.
Indaptus Therapeutics, Inc. (INDP) key data
| Price | $3.99 |
| Change (today) | +29.13% |
| Previous close | $3.09 |
| Market cap | $531.64M |
| EPS (TTM) | $-4.68 |
| 52-week high | $8.57 |
| 52-week low | $0.92 |
| Beta | 1.17 |
| Avg. volume | 762.8K |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently asked questions about Indaptus Therapeutics, Inc. (INDP)
How much does one share of Indaptus Therapeutics, Inc. cost?
As of the latest update, one share of Indaptus Therapeutics, Inc. (INDP) trades at $3.99 (+29.13% today).
What is Indaptus Therapeutics, Inc.'s market cap?
Indaptus Therapeutics, Inc. has a market capitalization of approximately $531.64M.
What is Indaptus Therapeutics, Inc.'s earnings per share (EPS)?
Indaptus Therapeutics, Inc.'s trailing twelve-month EPS is $-4.68.
Does Indaptus Therapeutics, Inc. pay a dividend?
Indaptus Therapeutics, Inc. does not currently pay a regular dividend.
What is Indaptus Therapeutics, Inc.'s 52-week trading range?
Over the past year, INDP has traded between $0.92 and $8.57.
Latest Indaptus Therapeutics, Inc. (INDP) news
- Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate UpdateNews · May 15, 2026
- Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate UpdateNews · Aug 13, 2026
- Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. LazarNews · Dec 29, 2025
- Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source SummitNews · Nov 17, 2025
- Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate UpdateNews · Nov 12, 2025
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live INDP dashboard…